Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9059-9067

  Narayanan, K ^a   Makino, S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

AGAR GEL ELECTROPHORESIS; ARTICLE; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; NORTHERN BLOTTING; PLASMID; PRIORITY JOURNAL; RNA PROCESSING; RNA TRANSCRIPTION; VIRUS PARTICLE; VIRUS PURIFICATION;

ANIMALS; MICE; MURINE HEPATITIS VIRUS; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; RNA, VIRAL; SIGNAL TRANSDUCTION; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

EID: 0034854123     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9059-9067.2001     Document Type: Article

References (84)

1. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions
2. Sequence and topology of a model intracellular membrane protein. E1 glycoprotein, from a coronavirus
3. An Mψ-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles
4. Interactions between coronavirus nucleocapsid protein and viral RNAs: Implications for viral transcription
5. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome
6. Experimental confirmation of a hepatitis B virus (HBV) epsilon-like bulge-and-loop structure in avian HBV RNA encapsidation signals
7. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region
8. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein
9. 5′ regions of HIV-1 RNAs are not sufficient for encapsidation: Implications for the HIV-1 packaging signal
10. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays
11. A subgenomic mRNA transcript of the coronavirus mouse hepatitis virus strain A59 defective interfering (DI) RNA is packaged when it contains the DI packaging signal
12. The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus
13. Sequencing of coronavirus IBV genomic RNA: A 195-base open reading frame encoded by mRNA B
14. Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins
15. Analysis of messenger RNA within virions of IBV
16. Electron microscopy of hepatitis B core antigen synthesized in E. coli
17. Identification of a bovine coronavirus packaging signal
18. Identification of nucleocapsid binding sites within coronavirus-defective genomes
19. Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles
20. Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues
21. Carboxy-terminal five amino acids of the nucleocapsid protein of vesicular stomatitis virus are required for encapsidation and replication of genome RNA
22. Complete sequence (20 kilobases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus
23. The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability
24. Analysis of constructed E gene mutants of mouse hepatitis virus confirms a pivotal role for E protein in coronavirus assembly
25. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis
26. Identification and characterization of a coronavirus packaging signal
27. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
28. Portable encapsidation signal of the L-A double-stranded RNA virus of S. cerevisiae
29. Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5′ HIV-1 genomic RNA sequence
30. Deletion analysis of the capsid protein of Sindbis virus: Identification of the RNA binding region
31. TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions
32. Bovine coronavirus genome
33. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture
34. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription
35. Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture
36. Tunicamycin resistant glycosylation of coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein
37. Replication of murine corona-virus defective interfering RNA from negative-strand transcripts
38. Sequences of the vesicular stomatitis virus matrix protein involved in binding to nucleocapsids
39. Assembled coronavirus from complementation of two defective interfering RNAs
40. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding
41. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus
42. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3
43. RNA of mouse hepatitis virus
44. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase
45. The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM
46. Association of the infectious bronchitis virus 3c protein with the virion envelope
47. Genome of infectious bronchitis virus
48. Amplification, expression, and packaging of foreign gene by influenza virus
49. Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells
50. Membrane topology of coronavirus E protein
51. A system for study of corona-virus mRNA synthesis: A regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion
52. High-frequency leader sequence switching during coronavirus defective interfering RNA replication
53. Defective-interfering particles of murine coronavirus: Mechanism of synthesis of defective viral RNAs
54. Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain
55. Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: Localization of a possible RNA-packaging signal
56. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import
57. Localization of an RNA-binding domain in the nucleocapsid protein of the coronavirus mouse hepatitis virus
58. Identification of a specific interaction between the coronavirus mouse hepatitis virus A59 nucleocapsid protein and packaging signal
59. Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells
60. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1
61. Mapping regions of the matrix protein of vesicular stomatitis virus which bind to ribonucleocapsids, liposomes, and monoclonal antibodies
62. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins
63. Identification of a region in the Sindbis virus nucleocapsid protein that is involved in specificity of RNA encapsidation
64. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59
65. The termini of VSV DI particle RNAs are sufficient to signal RNA encapsidation, replication, and budding to generate infectious particles
66. Encapsidation of turnip crinkle virus is defined by a specific packaging signal and RNA size
67. Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E
68. RNA-binding proteins of coronavirus MHV: Detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay
69. Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: Effect of tunicamycin
70. Minus-strand copies of replicating coronavirus mRNAs contain antileaders
71. Coronavirus mRNA synthesis involves fusion of non-contiguous sequences
72. Coronavirus multiplication strategy. I. Identification and characterization of virus-specified RNA
73. Coronavirus multiplication strategy. II. Mapping the avian infectious bronchitis virus intracellular RNA species to the genome
74. Specific interaction between coronavirus leader RNA and nucleocapsid protein
75. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid
76. - cells: Determination of the first site of budding of progeny virions
77. The 9-a hydrophobic protein encoded at the 3′ end of the porcine transmissible gastroenteritis coronavirus genome is membrane-associated
78. A domain at the 3′ end of the polymerase gene is essential for encapsidation of corona-virus defective interfering RNAs
79. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes
80. Evidence for specificity in the encapsidation of Sindbis virus RNAs
81. The 5′ terminal trailer region of vesicular stomatitis virus contains a position-dependent cis-acting signal for assembly of RNA into infectious particles
82. Murine coronavirus packaging signal confers packaging to nonviral RNA
83. Mouse hepatitis virus gene 5b protein is a new virion envelope protein
84. Presence of subgenomic mRNAs in virions of coronavirus IBV